Clinical utility of 13C-liver-function breath tests for assessment of hepatic function

Digestive Diseases and Sciences

Volumn 58, Issue 1, 2013, Pages 33-41

  Afolabi, P ^a   Wright, M ^b   Wootton, S A ^a   Jackson, A A ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

13C Liver function breath tests; Clinical evaluation; Clinical utility; Liver function

Indexed keywords

2 OXOISOCAPROIC ACID C 13; 4 ACETANISIDINE C 13; ACETYL CO ENZYME A C 13; AMINOANTIPYRINE C 13; AMINOPHENAZONE C 13; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CARBON 13; DIAGNOSTIC AGENT; FORMALDEHYDE C 13; GALACTOSE C 13; HOMOGENISTIC ACID C 13; HYDROXYPHENYLPYRUVATE C 13; METHIONINE C 13; OCTANOIC ACID C 13; PHENYLALANINE C 13; UNCLASSIFIED DRUG; CARBON;

ANTIVIRAL THERAPY; BREATH ANALYSIS; CLINICAL EVALUATION; COMMUNITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG METABOLISM; DRUG OXIDATION; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOTOPE LABELING; LIVER CIRRHOSIS; LIVER CYTOSOL; LIVER FIBROSIS; LIVER FUNCTION; LIVER FUNCTION BREAT TEST; LIVER FUNCTION TEST; LIVER METABOLISM; LIVER MICROSOME; LIVER MITOCHONDRION; NONALCOHOLIC FATTY LIVER; OUTPATIENT; PRIORITY JOURNAL; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; LIVER; LIVER DISEASE; METABOLISM; METHODOLOGY; PATHOLOGY;

BREATH TESTS; CARBON ISOTOPES; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS;

MLCS; MLOWN;

EID: 84873106685     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2340-z     Document Type: Review

References (65)

1. 13C-methionine breath test detects distinct hepatic mitochondrial dysfunction in HIV-infected patients with normal serum lactate. J Acquir Immune Defic Syndr. 2005;40:149-154.
2. 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther. 2002;16:717-725.
3. 13C- methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial. World J Gastroenterol. 2009;15:966-972.
4. 13C- phenylalanine breath test to evaluate functional capacity of hepatocyte in patients with liver cirrhosis and acute hepatitis. Aliment Pharmacol Ther. 2005;21:851-859.
5. 13C-phenylalanine breath test on predicting survival in patients with chronic liver failure. World J Gastroenterol. 2007;13:4579-4585.
6. Schmidt LE, Olsen AK, Stentoft K, Rasmussen A, Kirkegaard P, Dalhoff K. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients. Clin Pharmacol Ther. 2001;70:446-454.
7. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther. 2003;18:785-790.
8. Di Campli C, Angelini G, Armuzzi A, et al. Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation. Eur J Gastroenterol Hepatol. 2003;15:727-732.
9. Armuzzi A, Candelli M, Zocco MA, et al. Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther. 2002;16:1977-1996.
10. 13C-breath tests in hepatology (cytosolic liver function). Eur Rev Med Pharmacol Sci. 2004;8:47-49.
11. 13C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease. Am J Surg. 1997;173:270-273.
12. 13C] phenylalanine breath test reflects histological changes in the liver. J Surg Res. 2003;114:120-125.
13. Cuatrecasas P, Segal S. Mammalian galactokinase. Developmental and adaptive characteristics in the rat liver. J Biol Chem. 1965;240:2382-2388.
14. 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis. Scand J Gastroenterol. 2006;41:1336-1341.
15. 13C-aminopyrine breath test for the study of liver function in chronic liver disease. Clin Gastroenterol Hepatol. 2005;3:279-285.
16. Stibbe KJ, Verveer C, Francke J, et al. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Scand J Gastroenterol. 2011;46:962-972.
17. 13C-breath tests in the study of mitochondrial liver function. Eur Rev Med Pharmacol Sci. 2004;8:23-31.
18. 13C-breath tests for clinical investigation of liver mitochondrial function. Eur J Clin Invest. 2010;40:843-850.
19. Michaletz PA, Cap L, Alpert E, Lauterburg BH. Assessment of mitochondrial function in vivo with a breath test utilizing alpha-ketoisocaproic acid. Hepatology. 1989;10:829-832.
20. Honkoop P, de Man RA, Scholte HR, et al. Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B. Hepatology. 1997;26:211-215.
21. Lauterburg BH, Liang D, Schwarzenbach FA, Breen KJ. Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis. Hepatology. 1993;17:418-422.
22. 13C]ketoisocaproate is impaired in alcoholics. Alcohol Clin Exp Res. 1994;18:951-955.
23. Portincasa P, Grattagliano I, Lauterburg BH, Palmieri VO, Palasciano G, Stellaard F. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond). 2006;111:135-143.
24. Palmieri VO, Grattagliano I, Minerva F, Pollice S, Palasciano G, Portincasa P. Liver function as assessed by breath tests in patients with hepatocellular carcinoma. J Surg Res. 2009;157:199-207.
25. Mato JM, Alvarez L, Ortiz P, Pajares MA. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther. 1997;73:265-280.
26. 13C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study. HIV Med. 2011;12:40-45.
27. 13C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis. Eur J Med Res. 2011;16:258.
28. 13C-octanoic acid is preserved in patients with non-alcoholic steatohepatitis, but differs between women and men. Eur J Gastroenterol Hepatol. 2005;17:1181-1184.
29. 13C-octanoate breath test for patients with nonalcoholic steatohepatitis using the BreathID system. Hepatogastroenterology. 2009;56:1436-1438.
30. Perri F, Pastore M, Annese V, Andriulli A. The aminopyrine breath test. Ital J Gastroenterol. 1994;26:306-317.
31. 13C-breath tests in the study of microsomal liver function. Eur Rev Med Pharmacol Sci. 2004;8:33-46.
32. Bircher J, Kupfer A, Gikalov I, Preisig R. Aminopyrine demethylation measured by breath analysis in cirrhosis. Clin Pharmacol Ther. 1976;20:484-492.
33. Schneider JF, Baker AL, Haines NW, Hatfield G, Boyer JL. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. Gastroenterology. 1980;79:1145-1150.
34. Monroe PS, Baker AL, Schneider JF, Krager PS, Klein PD, Schoeller D. The aminopyrine breath test and serum bile acids reflect histologic severity in chronic hepatitis. Hepatology. 1982;2:317-322.
35. Vesell ES. Non invasive assessment in vivo of hepatic drug metabolism in health and disease. Ann NY acad sci. 1984;428:293-307.
36. Ilan Y. Review article: the assessment of liver function using breath tests. Aliment Pharmacol Ther. 2007;26:1293-1302.
37. 13C methacetin breath test for non-invasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT. J Viral Hepat. 2008;15:716-728.
38. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C. Dig Liver Dis. 2008;40:743-748.
39. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther. 2004;19:243.
40. 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels. World J Gastroenterol. 2005;11:142-148.
41. Lijmer JG, Leeflang M, Bossuyt PM. Proposals for a phased evaluation of medical tests. Med Decis Making. 2009;29:E13-E21.
42. Menzies D. Evaluating new diagnostic tests in the field - are we doing it right? BMC Proc. 2011;4:13.
43. Atkins D, Briss PA, Eccles M, et al. Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res. 2005;5:25.
44. 13C]isocaproate breath test to measure in vivo human mitochondrial function: application in alcoholic liver disease assessment. Alcohol Clin Exp Res. 2003;27:1293-1298.
45. 13C-aminopyrine breath test for the assessment of hepatic function. Isotopes Environ Health Stud. 2011;47:390-399.
46. 13C-breath tests to measure fat and carbohydrate digestion in clinical practice. Clinical Nutrition. 1995;14:149-154.
47. 2. Gastroenterology. 1976;71:98-101.
48. 13C]- bicarbonate kinetics in humans: intra- vs. interindividual variations. Am J Physiol. 1983;245:R190-R202.
49. Henderson G, Secor J, Heitman D, Schenker S. Effects of age and sex on the hepatic monoxygenase system: a correlative approach. Dev Pharmacol Ther. 1986;9:201-216.
50. Watkins PB. Noninvasive tests of CYP3A enzymes. Pharmacogenetics. 1994;4:171-184.
51. 13C-aminopyrine breath test results: a comparative study with histology, duplex-Doppler and a laboratory index in patients with chronic hepatitis C virus infection. Clin Exp Pharmacol Physiol. 2006;33:300-304.
52. 2 production rate in children? Isotopes Environ Health Stud. 2004;40:89-98.
53. 3 minus in normal adult males. J Nucl Med. 1970;11:711-715.
54. 13C-breath tests. Eur J Clin Nutr. 2006;60:69-76.
55. 13C mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child. 1997;76:349-351.
56. 13C-methacetin breath test shortened: 2-point-measurements after 15 minutes reliably indicate the presence of liver cirrhosis. J Clin Gastroenterol. 2007;41:33-37.
57. Forestier J, Dumortier J, Guillaud O, et al. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests. Eur J Gastroenterol Hepatol. 2010;22:532-540.
58. Ecochard M, Boillot O, Guillaud O, et al. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients. Clin Transplant. 2011;25:755-765.
59. Razlan H, Marzuki NM, Tai ML, Shamsul AS, Ong TZ, Mahadeva S. Diagnostic value of the C methacetin breath test in various stages of chronic liver disease. Gastroenterol Res Pract. 2011;2011:235796.
60. Morelli A, Narducci F, Pelli MA, Farroni F, Vedovelli A. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis. Am J Gastroenterol. 1981;76:110-113.
61. 13C]-aminopyrine in patients with liver cirrhosis. Proceeding of the Nutrition Society. 2009;68:E129.
62. Merkel C, Morabito A, Sacerdoti D, Bolognesi M, Angeli P, Gatta A. Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol. 1998;30:276-282.
63. Degre D, Bourgeois N, Boon N, et al. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transpl Int. 2004;17:31-38.
64. Merkel C, Bolognesi M, Bellon S. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut. 1992;33:836-842.
65. Ilan Y. A fourth dimension in decision making in hepatology. Hepatol Res. 2010;40:1143-1154.